Terns Pharmaceuticals, Inc. Common Stock (TERN) is a publicly traded Healthcare sector company. As of May 20, 2026, TERN trades at $52.95 with a market cap of $6.12B and a P/E ratio of -51.41. TERN moved +0.07% today. Year to date, TERN is +23.37%; over the trailing twelve months it is +1412.86%. Its 52-week range spans $1.87 to $53.19. Analyst consensus is neutral with an average price target of $52.97. Rallies surfaces TERN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Terns Pharmaceuticals, Inc. Common Stock (TERN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TERN moved +0.07% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $52.95 |
| Market Cap | $6.12B |
| P/E Ratio | -51.41 |
| EPS | $-1.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.19 |
| 52-Week Low | $1.87 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-96.21M |
| Gross Margin | 0.00% |
6 analysts cover TERN: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $52.97.